Exploring the Use of Complementary and Alternative Medicine in Cancer Patients

Jones, Ellen; Nissen, Lisa; McCarthy, Alexandra; Steadman, Kathryn J.; Windsor, Carol

doi:10.1177/1534735419854134

Cited by 58 publications

(24 citation statements)

References 108 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, in our FGDs there was a strong preference for natural remedies, which is in line with the increasing use of complementary medicine throughout the Western world. 30 31 In contrast, trial medication was also viewed as a possible treatment for current symptoms, which was a motivator for trial participation. This is in line with research in patients with early inflammatory arthritis, reporting that the prospect of direct medical benefit is a facilitator for prevention trial participation.…”

Section: Discussionmentioning

confidence: 99%

How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators

et al. 2021

View full text Add to dashboard Cite

ObjectivesSeveral trials to test the efficacy of a pharmacological intervention aimed at primary prevention of rheumatoid arthritis (RA) are ongoing or have recently been completed. A common issue in these trials is the severe difficulty with patient recruitment. In order to enhance recruitment, this qualitative study identified barriers and facilitators of individuals at risk of RA to participate in a prevention trial.MethodsIndividuals at risk of developing RA (ie, arthralgia with anticitrullinated protein antibodies and/or rheumatoid factor without arthritis), who had previously been asked to participate in a prevention trial, participated in focus group discussions (n=18) exploring their facilitators and barriers for trial participation. Thematic analysis identified factors that were important in at-risk individuals’ decision about trial participation.ResultsThe prospect of personal benefit, the acknowledgement of one’s symptoms and the desire to contribute to society facilitated trial participation. In contrast, misconception about what it means to be at risk, or about the aim of the prevention trial, negative views on trial medication, and a low perceived urgency to act on the possibility of developing RA versus a high perceived burden of participating in a trial discouraged participation.ConclusionsTo enhance inclusion in trials aimed to prevent RA, the results suggest to use strategies such as optimising education about RA, personal risk, trial aim and trial medication, explicitly addressing misconceptions and concerns, using tools to improve information provision, limiting study burden in trial design and encouraging physicians to mention trial participation.

show abstract

Section: Discussionmentioning

confidence: 99%

How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Many factors can explain variations in healthcare [19]. First, factors related to geographical regions might affect the demand for complementary therapies, such as patients' attitudes towards these treatments, cultural-related factors, the comorbidity of patients, or socioeconomic factors [20]. Second, differences in the supply of complementary therapies can also exist.…”

Section: Discussionmentioning

confidence: 99%

What is offered and treated by non-medical complementary therapists in Switzerland: Results from a national web survey

Barth

Maier

Lebet³

et al. 2020

European Journal of Integrative Medicine

View full text Add to dashboard Cite

Introduction: Complementary therapy is implemented in Switzerland on a legal basis (i.e. by constitution) and can be reimbursed if offered either by physicians or by private health insurance coverage from non-medical therapists. This survey wanted to explore different types of interventions across Switzerland and to identify the most relevant complaints treated by therapists, their job satisfaction and satisfaction concerning the collaboration with medical doctors. Methods: This cross sectional study of therapists registered in the Experience Medicine Register (EMR) was conducted as online survey in 2017 in Switzerland in three different languages. Therapists first selected one possible treatment option as their most often used intervention for their patients. Afterwards, they indicated the complaints treated with this kind of intervention. Data were analysed descriptively. Results: Of 17,647 initially invited therapists 3942 responded (22.3%) and data from 3638 therapists could be analysed. Therapists were often females in their own practice and they had high job satisfaction, but were less satisfied with the collaboration with medical doctors. Therapists stated that they most often provide classical massage, craniosacral therapy, Traditional Chinese Medicine, naturopathic practices and medical massage. French speaking therapists stated that they more often provided osteopathy and manual lymphatic drainage but less often craniosacral therapy compared with the German speaking therapists. Headache and back pain were named as the most common treated complaints. Conclusions: Therapies used by non-medical complementary therapists varied across the different regions in Switzerland. However, we found no regional differences in the complaints being treated by therapists.

show abstract

“…Cancer cachexia (anorexia, weight loss, loss of adipose tissue and skeletal muscle) is reported in 30%-80% cancer patients and causes 20% of all cancer deaths [379]. Worldwide, some 60%-80% people depend on alternative medicines [380][381][382], which is also true for nearly 40% to 70% European [383,384], 50% Italian, 40% Korean, 30% British [385] and up to 87% of Australian cancer patients [386]. Use of unapproved/ unlabeled/wrong herbal treatment is not uncommon [387,388] and also drug interactions reported phytotherapeutics in oncology [389].…”

Section: Cancer Carementioning

confidence: 99%

Clinical Pharmacists in Chronic Care

Mohiuddin¹

2019

GJMR

View full text Add to dashboard Cite

Pharmacy practice has changed significantly lately. The professionals have the chance to contribute straightforwardly to patient consideration so as to lessen morbimortality identified with medication use, promoting wellbeing and preventing diseases. Healthcare organizations worldwide are under substantial pressure from increasing patient demand. Unfortunately, a cure is not always possible particularly in this era of chronic complications, and the role of physicians has become limited to controlling and palliating symptoms.The increasing population of patients with longterm conditions are associated with high levels of morbidity, healthcare costs and GP workloads. Clinical pharmacy took over an aspect of medical care that had been partially abandoned by physicians. Overburdened by patient loads and the explosion of new drugs, physicians turned to pharmacists more and more for drug information, especially within institutional settings. Once relegated to counting and pouring, pharmacists headed institutional reviews of drug utilization and served as consultants to all types of health-care facilities. In addition, when clinical pharmacists are active members of the care team, they enhance proficiency by: Providing critical input on medicine use and dosing. Working with patients to solve problems with their medications and improve compliance.

show abstract

Exploring the Use of Complementary and Alternative Medicine in Cancer Patients

Cited by 58 publications

References 108 publications

How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators

How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators

What is offered and treated by non-medical complementary therapists in Switzerland: Results from a national web survey

Clinical Pharmacists in Chronic Care

Contact Info

Product

Resources

About